In the current large-scale study, we demonstrated that the influence of the PNPLA3 genetic variants in hepatic steatosis remains consistent in Asian CHC populations, and the effect is independent of other metabolic disorders. This evidence concerns the gene PNPLA3 and metabolic disease.